These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5054584)

  • 1. Identification of 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin as a metabolite of 5,5-diphenylhydantoin (phenytoin) in rats and man.
    Borgå O; Garle M; Gutová M
    Pharmacology; 1972; 7(3):129-37. PubMed ID: 5054584
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of urinary catechol and methylated catechol metabolites of phenytoin in humans, monkeys, and dogs by GLC and GLC-mass spectrometry.
    Midha KK; Hindmarsh KW; McGilveray IJ; Cooper JK
    J Pharm Sci; 1977 Nov; 66(11):1596-602. PubMed ID: 410919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of 5-meta-hydroxyphenyl-5-phenylhydantoin as a metabolite of diphenylhydantoin.
    Atkinson AJ; MacGee J; Strong J; Garteiz D; Gaffney TE
    Biochem Pharmacol; 1970 Aug; 19(8):2483-91. PubMed ID: 5520606
    [No Abstract]   [Full Text] [Related]  

  • 4. A 3-O-methylated catechol metabolite of diphenylhydantoin (Dilantin) in rat urine.
    Chang T; Okerholm RA; Glazko AJ
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):13-23. PubMed ID: 4671868
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative estimation of catechol/methylcatechol pathways in human phenytoin metabolism.
    Maguire JH
    Epilepsia; 1988; 29(6):753-9. PubMed ID: 3191891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereochemical aspects of the metabolism of 5-(4'-fluorophenyl)-5-phenylhydantoin in the rat.
    Poupaert JH; Adline J; Claesen MH; De Laey P; Dumont PA
    J Med Chem; 1979 Sep; 22(9):1140-2. PubMed ID: 490562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a catechol glucuronide metabolite of 5,5-diphenylhydantoin (DPH) in rat bile by gas chromatography (GC) and mass spectrometry (MS).
    Gerber N; Seibert RA; Thompson RM
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):499-511. PubMed ID: 4750099
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary excretion of 4-hydroxy-3-methoxyphenylglycol and 4-hydroxy-3-methoxyphenylethanol in man and rat.
    Karoum F; Lefèvre H; Bigelow LB; Costa E
    Clin Chim Acta; 1973 Jan; 43(1):127-37. PubMed ID: 4710814
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative assay of 5,5-diphenylhydantoin (Dilantin) and 5-(p-hydroxyphenyl)-5-phenylhydantoin by gas-liquid chromatography.
    Chang T; Glazko AJ
    J Lab Clin Med; 1970 Jan; 75(1):145-55. PubMed ID: 5410494
    [No Abstract]   [Full Text] [Related]  

  • 10. 5,5-Bis(3-hydroxyphenyl)hydantoin, a minor metabolite of diphenylhydantoin (dilantin) in the rat and human.
    Thompson RM; Beghin J; Fife WK; Gerber N
    Drug Metab Dispos; 1976; 4(4):349-56. PubMed ID: 8289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct high-performance liquid chromatographic analysis of p-hydroxyphenyl-phenylhydantoin glucuronide, the final metabolite of phenytoin, in human serum and urine.
    Vree TB; Steegers-Theunissen RP; Baars AM; Hekster YA
    J Chromatogr; 1990 Apr; 526(2):581-9. PubMed ID: 2362000
    [No Abstract]   [Full Text] [Related]  

  • 12. Sex differences in rats in the metabolism of phenytoin to 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin.
    Billings RE
    J Pharmacol Exp Ther; 1983 Jun; 225(3):630-6. PubMed ID: 6864524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of 5-(3,4-Dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin (Dihydrodiol) and quantitative studies of phenytoin metabolism in man.
    Maguire JH; Kraus BL; Butler TC; Dudley KH
    Ther Drug Monit; 1979; 1(3):359-70. PubMed ID: 555579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute configurations of the dihydrodiol metabolites of 5,5-diphenylhydantoin (phenytoin) from rat, dog, and human urine.
    Maguire JH; Butler TC; Dudley KH
    Drug Metab Dispos; 1980; 8(5):325-31. PubMed ID: 6107230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.
    Claesen M; Moustafa MA; Adline J; Vandervorst D; Poupaert JH
    Drug Metab Dispos; 1982; 10(6):667-71. PubMed ID: 6130920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen-18 incorporation studies of the metabolism of phenytoin to the catechol.
    Billings RE; Fischer LJ
    Drug Metab Dispos; 1985; 13(3):312-7. PubMed ID: 2861989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaschromatographic estimation of 3,4-dihydroxy-phenylglycol in urine as the diacetyl-phenyl-bis-(trimethyl)silyl ether.
    Kahane Z; Jindal SP; Vestergaard P
    Clin Chim Acta; 1976 Nov; 73(1):203-6. PubMed ID: 1000832
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of 5-(p-hydroxyphenyl)-5-phenylhydantoin and studies relating to the disposition of phenytoin in man.
    Witkin KM; Bius DL; Teague BL; Wiese LS; Boyles LW; Dudley KH
    Ther Drug Monit; 1979; 1(1):11-34. PubMed ID: 553326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The determination of 4-hydroxy-3-methoxyphenylethylene glycol in urine and CSF using gas chromatography.
    Bond PA
    Biochem Med; 1972 Feb; 6(1):36-45. PubMed ID: 4260101
    [No Abstract]   [Full Text] [Related]  

  • 20. Single and multiple ion recording techniques for the analysis of diphenylhydantoin and its major metabolite in plasma.
    Baty JD; Robinson PR
    Biomed Mass Spectrom; 1977 Feb; 4(1):36-41. PubMed ID: 836941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.